Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3113 participants.

Also called NCT06475625

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 3,113 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06475625
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06475625. Non-randomized; no masking; primary purpose treatment. Start 2019-10-22 (actual); primary completion 2025-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease
Acronym
OKAY
Condition
Chronic Kidney Diseases
Intervention (Procedure)
Percutaneous coronary intervention
Intervention (Device)
Orsiro™ or Orsiro_Mission™ stent
Lead sponsor
The Catholic University of Korea (class: other)

Record details

Record id
cardio:ct-nct06475625
Content hash
a2b5a82a75ed689058602d9e49d2cddb2291c91cf388987970e33dbc9ac1a2fe